455 related articles for article (PubMed ID: 26028026)
1. Oncogenic PI3K and K-Ras stimulate de novo lipid synthesis through mTORC1 and SREBP.
Ricoult SJ; Yecies JL; Ben-Sahra I; Manning BD
Oncogene; 2016 Mar; 35(10):1250-60. PubMed ID: 26028026
[TBL] [Abstract][Full Text] [Related]
2. Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma.
Calvisi DF; Wang C; Ho C; Ladu S; Lee SA; Mattu S; Destefanis G; Delogu S; Zimmermann A; Ericsson J; Brozzetti S; Staniscia T; Chen X; Dombrowski F; Evert M
Gastroenterology; 2011 Mar; 140(3):1071-83. PubMed ID: 21147110
[TBL] [Abstract][Full Text] [Related]
3. Connecting mTORC1 signaling to SREBP-1 activation.
Bakan I; Laplante M
Curr Opin Lipidol; 2012 Jun; 23(3):226-234. PubMed ID: 22449814
[TBL] [Abstract][Full Text] [Related]
4. FGFR3 stimulates stearoyl CoA desaturase 1 activity to promote bladder tumor growth.
Du X; Wang QR; Chan E; Merchant M; Liu J; French D; Ashkenazi A; Qing J
Cancer Res; 2012 Nov; 72(22):5843-55. PubMed ID: 23019225
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis.
Yi J; Zhu J; Wu J; Thompson CB; Jiang X
Proc Natl Acad Sci U S A; 2020 Dec; 117(49):31189-31197. PubMed ID: 33229547
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of mTOR complex 2 induces GSK3/FBXW7-dependent degradation of sterol regulatory element-binding protein 1 (SREBP1) and suppresses lipogenesis in cancer cells.
Li S; Oh YT; Yue P; Khuri FR; Sun SY
Oncogene; 2016 Feb; 35(5):642-50. PubMed ID: 25893295
[TBL] [Abstract][Full Text] [Related]
7. Opposite feedback from mTORC1 to H-ras and K-ras4B downstream of SREBP1.
Posada IMD; Lectez B; Siddiqui FA; Oetken-Lindholm C; Sharma M; Abankwa D
Sci Rep; 2017 Aug; 7(1):8944. PubMed ID: 28827765
[TBL] [Abstract][Full Text] [Related]
8. Positive feedback loop between PI3K-Akt-mTORC1 signaling and the lipogenic pathway boosts Akt signaling: induction of the lipogenic pathway by a melanoma antigen.
Yamauchi Y; Furukawa K; Hamamura K; Furukawa K
Cancer Res; 2011 Jul; 71(14):4989-97. PubMed ID: 21632551
[TBL] [Abstract][Full Text] [Related]
9. mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway.
Peterson TR; Sengupta SS; Harris TE; Carmack AE; Kang SA; Balderas E; Guertin DA; Madden KL; Carpenter AE; Finck BN; Sabatini DM
Cell; 2011 Aug; 146(3):408-20. PubMed ID: 21816276
[TBL] [Abstract][Full Text] [Related]
10. Activation of a metabolic gene regulatory network downstream of mTOR complex 1.
Düvel K; Yecies JL; Menon S; Raman P; Lipovsky AI; Souza AL; Triantafellow E; Ma Q; Gorski R; Cleaver S; Vander Heiden MG; MacKeigan JP; Finan PM; Clish CB; Murphy LO; Manning BD
Mol Cell; 2010 Jul; 39(2):171-83. PubMed ID: 20670887
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of SREBP inhibits tumor growth and initiation by altering cellular metabolism in colon cancer.
Wen YA; Xiong X; Zaytseva YY; Napier DL; Vallee E; Li AT; Wang C; Weiss HL; Evers BM; Gao T
Cell Death Dis; 2018 Feb; 9(3):265. PubMed ID: 29449559
[TBL] [Abstract][Full Text] [Related]
12. Insulin-induced de novo lipid synthesis occurs mainly via mTOR-dependent regulation of proteostasis of SREBP-1c.
Dong Q; Majumdar G; O'Meally RN; Cole RN; Elam MB; Raghow R
Mol Cell Biochem; 2020 Jan; 463(1-2):13-31. PubMed ID: 31541353
[TBL] [Abstract][Full Text] [Related]
13. mTORC1 upregulation via ERK-dependent gene expression change confers intrinsic resistance to MEK inhibitors in oncogenic KRas-mutant cancer cells.
Komatsu N; Fujita Y; Matsuda M; Aoki K
Oncogene; 2015 Nov; 34(45):5607-16. PubMed ID: 25703330
[TBL] [Abstract][Full Text] [Related]
14. Why does tumor-associated fatty acid synthase (oncogenic antigen-519) ignore dietary fatty acids?
Menendez JA; Colomer R; Lupu R
Med Hypotheses; 2005; 64(2):342-9. PubMed ID: 15607569
[TBL] [Abstract][Full Text] [Related]
15. Activation of mTOR modulates SREBP-2 to induce foam cell formation through increased retinoblastoma protein phosphorylation.
Ma KL; Liu J; Wang CX; Ni J; Zhang Y; Wu Y; Lv LL; Ruan XZ; Liu BC
Cardiovasc Res; 2013 Dec; 100(3):450-60. PubMed ID: 24068000
[TBL] [Abstract][Full Text] [Related]
16. Neuregulin-activated ERBB4 induces the SREBP-2 cholesterol biosynthetic pathway and increases low-density lipoprotein uptake.
Haskins JW; Zhang S; Means RE; Kelleher JK; Cline GW; Canfrán-Duque A; Suárez Y; Stern DF
Sci Signal; 2015 Nov; 8(401):ra111. PubMed ID: 26535009
[TBL] [Abstract][Full Text] [Related]
17. Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes.
Jhanwar-Uniyal M; Gillick JL; Neil J; Tobias M; Thwing ZE; Murali R
Adv Biol Regul; 2015 Jan; 57():64-74. PubMed ID: 25442674
[TBL] [Abstract][Full Text] [Related]
18. Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways.
Yecies JL; Zhang HH; Menon S; Liu S; Yecies D; Lipovsky AI; Gorgun C; Kwiatkowski DJ; Hotamisligil GS; Lee CH; Manning BD
Cell Metab; 2011 Jul; 14(1):21-32. PubMed ID: 21723501
[TBL] [Abstract][Full Text] [Related]
19. Pyruvate kinase M2 interacts with nuclear sterol regulatory element-binding protein 1a and thereby activates lipogenesis and cell proliferation in hepatocellular carcinoma.
Zhao X; Zhao L; Yang H; Li J; Min X; Yang F; Liu J; Huang G
J Biol Chem; 2018 Apr; 293(17):6623-6634. PubMed ID: 29514980
[TBL] [Abstract][Full Text] [Related]
20. SREBP1 regulates mitochondrial metabolism in oncogenic KRAS expressing NSCLC.
Ruiz CF; Montal ED; Haley JA; Bott AJ; Haley JD
FASEB J; 2020 Aug; 34(8):10574-10589. PubMed ID: 32568455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
